Research Project in association with Protocol WN25203 "CSF sample retention for biomarker assay development" [SUBSTUDY OF 700060548]
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Gantenerumab (Primary)
- Indications Alzheimer's disease
- Focus Biomarker; Therapeutic Use
- Sponsors Roche
- 06 May 2014 New trial record